SCHEMBL25817750

SCHEMBL25817750

c1cc(-c2ccc3ccc(-c4ccc5ccccc5c4)cc3c2)cc(-c2nc(-c3ccc4ccccc4c3)nc(-c3ccc4c(c3)sc3ccccc34)n2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B1 P14061 2/20 0.41
HSD17B2 P37059 2/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
RAB9A P51151 1/20 0.41
GPR3 P46089 1/20 0.39
CYP17A1 P05093 1/20 0.39
CYP19A1 P11511 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
CYP1A2 P05177 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
SIRT2 Q8IXJ6 4/20 0.36
ESR1 P03372 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23518911 0.99 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1HSD17B1HSD17B2MAPT
SCHEMBL25817720 0.97 ESR1 (0.39) SMN1; SMN2ALDH1A1HSD17B1HSD17B2MAPT
SCHEMBL25817774 0.96 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1HSD17B1HSD17B2MAPT
SCHEMBL24123198 0.96 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1HSD17B1HSD17B2MAPT
SCHEMBL24123237 0.95 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1HSD17B1HSD17B2MAPT
SCHEMBL25818453 0.94 ALDH1A1 (0.36) SMN1; SMN2ALDH1A1HSD17B1HSD17B2MAPT
SCHEMBL26686296 0.93 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1HSD17B1HSD17B2MAPT
SCHEMBL24266756 0.93 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1MAPTHPGDRAB9A
SCHEMBL21707173 0.93 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1MAPTHPGDRAB9A
SCHEMBL21109832 0.92 CYP1A1 (0.44) SMN1; SMN2ALDH1A1HSD17B1HSD17B2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 SMN1; SMN2 474/4885ALDH1A1 1010/4885HSD17B1 3460/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 SMN1; SMN2 474/4885ALDH1A1 1010/4885HSD17B1 3460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.